Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

Université de Montréal

$17,500.00

Novel therapeutic approaches targeting the development of medulloblastoma

EF 2018-19

Résumé
TThe most frequent solid pediatric cancer is medulloblastoma, a brain tumour. The prognostic of this cancer is very variable depending on its specific subtype. Approximately 30% of medulloblastomas are of the Sonic Hedgehog (SHH) subtype, which leads to a limited prognosis. The actual treatment available to these children includes surgery, radiotherapy, and chemotherapy. They offer a limited efficacy, and cause serious adverse effects including permanent cognitive decline caused by radiotherapy. In the last years, researchers began to better understand the molecular underpinnings of this disease. Our research project objective is to better characterize specific molecular mechanisms of SHH medulloblastoma, and develop a targeted treatment designed to increase patients’ survival while decreasing the adverse effects of the currently available treatments. Our project will specifically target the mechanisms by which the activation of the SHH pathway leads to DNA damage. This research will be done using in vitro assays and in vivo animal experimentation on mice. If the efficacy of the tested treatment is confirmed, it may lead to its testing in a clinical research protocol.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
406415
Name
Racicot Frédéric
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Novel therapeutic approaches targeting the development of medulloblastoma
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Cerebellum; Children'S Health; Genetics; Homologous Recombination; Medulloblastoma; Mice; Molecular Biology; Nervous System; Sonic Hedgehog
Abstract
TThe most frequent solid pediatric cancer is medulloblastoma, a brain tumour. The prognostic of this cancer is very variable depending on its specific subtype. Approximately 30% of medulloblastomas are of the Sonic Hedgehog (SHH) subtype, which leads to a limited prognosis. The actual treatment available to these children includes surgery, radiotherapy, and chemotherapy. They offer a limited efficacy, and cause serious adverse effects including permanent cognitive decline caused by radiotherapy. In the last years, researchers began to better understand the molecular underpinnings of this disease. Our research project objective is to better characterize specific molecular mechanisms of SHH medulloblastoma, and develop a targeted treatment designed to increase patients’ survival while decreasing the adverse effects of the currently available treatments. Our project will specifically target the mechanisms by which the activation of the SHH pathway leads to DNA damage. This research will be done using in vitro assays and in vivo animal experimentation on mice. If the efficacy of the tested treatment is confirmed, it may lead to its testing in a clinical research protocol.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Racicot, Frédéric
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~